Stock market Updates | Krebs Biochemicals & Industries Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY14310.80  -524.05 (-3.53%)
SENSEX47883.38  -1707.94 (-3.44%)
  • top gainers
  • top losers
  • top volume
  • top value
investments Associate Login Online Trading Login
  • indian indices
  • global indices

We are investment service provider for Buy stocks , Low Stocks Brokerage , Stocks Portfolio Management in Surat , NRI Investment in Stocks , Share Broking Surat , Stock Broking Surat , Advisory Services Surat and Competetive Stocks Brokerage. investment advisory, financial integrity and prompt services in the whole of South Gujarat.

L
equity
Home Markets & NewsCompany ProfileSmart Quotes

KREBS BIOCHEMICALS & INDUSTRIES LTD.

NSE : KREBSBIOBSE : 524518ISIN CODE : INE268B01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE100.50-13.65 (-11.96 %)
PREV CLOSE (Rs.) 114.15
OPEN PRICE (Rs.) 114.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12080
TODAY'S LOW / HIGH (Rs.)97.10 114.00
52 WK LOW / HIGH (Rs.)63.05 147.7
NSE100.85-13.2 (-11.57 %)
PREV CLOSE( Rs. ) 114.05
OPEN PRICE (Rs.) 115.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 58064
TODAY'S LOW / HIGH(Rs.) 97.20 117.00
52 WK LOW / HIGH (Rs.)64.4 148.8

Smart Quotes

BSE NSE
1D 1M 3M 1Y 3Y 5Y
Stock Summary
Trade Value (Rs. in Lacs)
12.69
Dividend Yield(%)
0.00
TTM EPS (Rs.)
-12.77
P/E Ratio
0.00
Book Value (Rs.)
-16.22
Face Value (Rs.)
10
MCap (Rs. in Mn)
2177.62
Price/Earning (TTM)
-9.64
Price/Sales (TTM)
6.09
Price/Book (MRQ)
-6.23
PAT Margin (%)
-86.41
ROCE (%)
-56.95
company info
Incorporation Year : 02-12 1991

Management Info :

R T Ravi - Chairman Avinash Ravi - Managing Director

Registered Office :

Address : Kothapalli Village,Anakapalli,Kasimkota Mandal,
Vishakhapatnam,
Andhra Pradesh-531031

Phone :

Registrars Details :

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
News
07Apr Announcement under Regulation 30 (LOD
.Pursuant to the exercise of further conversion option by Ipca Laborator..
06Apr Allotment Of 1940000 Shares Upon Conv
Pursuant to the exercise of further conversion option by Ipca Laboratori..
06Apr Allotment of Equity Shares
inter alia, 1.Pursuant to our intimation letters dated 1st February, 202..
more
Financials
QTR Dec 20 ANNUAL 20
Net Profit-82.61-288.72
Gross Profit -82.61 -288.72
Operating Profit -55.95 -182.65
Net Sales 95.78 334.12
more
Rs. in Millions
Rolling Forward P/E (EOD)
Event Calendar
peer group
Dr. Reddys Lab (BSE)
Rwadiwala-peer-arrow  4989.20 (4.83%)
M.Cap (Rs. in Cr)82971.01
Astrazeneca Pharma I (BSE)
Rwadiwala-peer-arrow  3398.00 (2.51%)
M.Cap (Rs. in Cr)8495.00
Solara Active Pharma (BSE)
Rwadiwala-peer-arrow  1440.90 (5.11%)
M.Cap (Rs. in Cr)5177.12
Ipca Laboratories (BSE)
Rwadiwala-peer-arrow  2153.75 (3.29%)
M.Cap (Rs. in Cr)27389.27
Shareholding Pattern
PROMOTERS
70.03%
NON-INSTITUTION
29.96%
FI/BANKS/INSURANCE
0%
MUTUAL FUNDS/UTI
0%
GOVERNMENT
0%
FII
0%
more
Mf Holdings
Scheme Name
Hold(%)
No Data Found
ATTENTION INVESTORS|KYC|IPO|PROPRIETARY TRADING
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors.    
CORPORATE OFFICE
address
  • 9/2003-4,
  • Vishnu Priya Limda Chowk
  • Main Road
  • Surat – 395 003.
fax us @ +91-261-6673537
email us @ info@rwadiwala.com

Feed Back  | Terms & Conditions  | SEBI  | FMC  | NSE  | BSE  | MCX  | NCDEX  | IRDA  |  AMFI  | Disclaimer  | Privacy Policy  | Careers | User Agreements  | Ethics Policy  | Investor Protection  |  Dos and Don'ts   |  Rights and Obligations   |  Uniform Risk Disclosure   |   Important Policies   |  To File A Complaint on SCORES   | Sitemap 

SEBI Regn No. BSE - CM/F&O, NSE - CM/F&O/CDS: INZ000187332 | SEBI PMS regn no.: INP000004045 | MCX & NCDEX SEBI Regn No.: INZ000080636 | CDSL DP ID: 12043100
| R Wadiwala Securities Pvt Ltd - CIN: U67120GJ2004PTC044324 | R Wadiwala Commodities Pvt Ltd - CIN: U51109GJ2007PTC050176

Compliance Officer - Email ID: compliance@rwadiwala.com | Contact No.: 0261-6673542

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by us, our employees, and our servants.

Investor Greivance Redressal at support@rwadiwala.com

Copyright © 2016 | All Rights Reserved. R.Wadiwala group.

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.